ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 202 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $796,000 | -17.4% | 32,877 | -20.4% | 0.07% | -17.3% |
| Q4 2021 | $964,000 | +56.0% | 41,294 | +11.1% | 0.08% | +32.8% |
| Q3 2021 | $618,000 | -10.8% | 37,184 | +30.8% | 0.06% | -15.3% |
| Q2 2021 | $693,000 | +3050.0% | 28,426 | +6026.3% | 0.07% | +3500.0% |
| Q2 2020 | $22,000 | +175.0% | 464 | +148.1% | 0.00% | +100.0% |
| Q1 2020 | $8,000 | +33.3% | 187 | +40.6% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | -57.1% | 133 | -66.8% | 0.00% | -66.7% |
| Q3 2019 | $14,000 | +75.0% | 401 | +32.8% | 0.00% | +50.0% |
| Q2 2019 | $8,000 | -11.1% | 302 | +0.7% | 0.00% | 0.0% |
| Q4 2017 | $9,000 | -10.0% | 300 | +18.1% | 0.00% | 0.0% |
| Q3 2017 | $10,000 | 0.0% | 254 | -29.8% | 0.00% | 0.0% |
| Q2 2017 | $10,000 | 0.0% | 362 | +29.3% | 0.00% | -33.3% |
| Q1 2017 | $10,000 | 0.0% | 280 | -18.6% | 0.00% | 0.0% |
| Q4 2016 | $10,000 | – | 344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |